James Tribble

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Rupali Vohra

Københavns Universitet

DENMARK

View details

Xuewei Wang

Assistant Professor

University of South Florida

UNITED STATES

View details

Pete Williams

Karolinska Institutet

SWEDEN

View details

Ephraim F. Trakhtenberg

UNITED STATES

View details

Luis Alarcon-Martinez

University of Melbourne

AUSTRALIA

View details

Brian Clark

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Sevannah Steeves

The University of Queensland Queensland Brain Institute

AUSTRALIA

View details

Thomas Johnson

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Pratheepa kumari Rasiah

Assistant Professor (Research)

Vanderbilt University

UNITED STATES

View details

Alberto Dominguez-Vicent

Assistant professor

Karolinska Institutet

SWEDEN

View details

Romanas Chaleckis

Assistant Professor

Nagoya University

JAPAN

View details

Anna Hagström

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Tribble

Research Interests

Explore related searches

Contact this professor

Articles (19)

Identifying potential key metabolic pathways and biomarkers in glaucoma: a systematic review and meta-analysis

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production

NMNAT2 is a druggable target to drive neuronal NAD production

Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume

Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters

NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve

Glial metabolic alterations during glaucoma pathogenesis

Nicotinamide Prevents Retinal Vascular Dropout in a Rat Model of Ocular Hypertension and Supports Ocular Blood Supply in Glaucoma Patients

Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium

Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection

Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients.

Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model.

Comparative Assessment of Retinal Blood Flow Velocity Changes Following Brimonidine and Brinzolamide Administration Using Retinal Function Imaging.

Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma

Retinal Ganglion Cell Degeneration in a Rat Magnetic Bead Model of Ocular Hypertensive Glaucoma.

Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection

Collaborators (12)

Rupali Vohra

Xuewei Wang

Pete Williams

Ephraim F. Trakhtenberg

Luis Alarcon-Martinez

Brian Clark

Sevannah Steeves

Thomas Johnson

Pratheepa kumari Rasiah

Alberto Dominguez-Vicent

Romanas Chaleckis

Anna Hagström

Make your next move.